Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
TNDM Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
7.30%
Analyst Rating:
BUY
Analyst Forecast (1yr):
38.50%
TNDM Stock Analysis
TNDM
PE Ratio:
TNDM
PEG Ratio:
Not Available
TNDM
Forward EPS Growth (12 month):
0.00%
TNDM
PS Ratio:
1.2
TNDM
PSG Ratio:
0.1
TNDM
Forward Revenue Growth (12 month):
12.50%
TNDM Articles
No data was found